Acceptable Pressure Range for Continuous Positive Airway Pressure(CPAP) Treatment
NCT ID: NCT04925466
Last Updated: 2022-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-06-05
2021-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea
NCT03782844
Comparison Between Auto CPAP and Fixed CPAP in Chinese Patients With OSA
NCT00307424
Continuous Positive Airway Pressure (PAP) Titration and Treatment Versus Auto-adjusting PAP Treatment for Sleep Apnea
NCT00988351
Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Changes of Blood Pressure Between Day and Night
NCT01865864
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
NCT04712656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment with CPAP at 10cmH2O
Patients with OSA will be treated with CPAP at 10cmH2O during sleep.
CPAP at pressure of 10 cmH2O
Patients used CPAP with the pressure of 10 cmH2O during overnight polysomnography
Treatment with CPAP at minimal effective pressure
Patients with OSA will be treated with CPAP at minimal effective pressure derived from manual titration during sleep.
CPAP at minimal effective pressure
Patients with OSA will be treated with CPAP at minimal effective pressure derived from manual titration during sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPAP at pressure of 10 cmH2O
Patients used CPAP with the pressure of 10 cmH2O during overnight polysomnography
CPAP at minimal effective pressure
Patients with OSA will be treated with CPAP at minimal effective pressure derived from manual titration during sleep.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. a diagnosis of obstructive sleep apnea with polysomnography according to ASSM guideline(apnoea-hypopnea-index(AHI)≥5 events/h) and need to be treated with continuous positive airway pressure;
3. willing to participate after informed consent.
Exclusion Criteria
2. Severe respiratory disease defined as severe chronic obstructive pulmonary disease(ie. FEV1/FVC\<70% and FEV1\<50%predicted) or resting awake SaO2\<90%
3. Have known contraindications with CPAP, like current pneumothorax and hemoptysis, et al.
4. Central sleep apnea\>10 events/h;
5. Frequent nasal congestion;
6. Optimal treatment CPAP pressure(by manual titration) equal or higher than 10cmH2O.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State Key Laboratory of Respiratory Disease
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yuan-Ming Luo
Proffessor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuanming Luo, PhD
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital of Guangzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang L, Chen Y, Wei Q, Wu Y, Huang C, Liang S, Steier J, Catcheside P, Eckert D, Wellman A, Luo Y. Fixed CPAP at 10 cmH 2O May Replace Manual Titration in Moderate to Severe OSA Patients: A Preliminary Randomised Controlled Trial. Respirology. 2025 Aug;30(8):770-778. doi: 10.1111/resp.70037. Epub 2025 Mar 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.